Literature DB >> 33573845

A Model for Predicting Malignant Sub-pleural Solid Masses Using Grayscale Ultrasound and Ultrasound Elastography.

Wanbin Li1, Mengjun Shen2, Yi Zhang2, Yang Cong2, Huiming Zu2, Hongwei Chen2, Yin Wang2.   

Abstract

This article aimed to establish a prediction model of grayscale sonography and ultrasound elastography for malignant sub-pleural solid masses and evaluate its diagnostic value. The study included 153 patients, including 89 patients with malignant tumors and 64 patients with benign diseases. Statistical differences between the malignant and benign groups were found in the factors of age, air bronchogram, borderline, shape and elasticity score (p < 0.05). Age, elasticity score and borderline were effective factors for predicting malignant sub-pleural solid masses, offering an area under the receiver operating characteristic curve (AUROC) value of 0.72 (95% confidence interval [CI] 0.64-0.80), 0.73 (95% CI 0.65-0.79) and 0.70 (95% CI 0.62-0.77), respectively. The AUROC value of the prediction model for malignant sub-pleural solid masses was 0.88 (95% CI 0.81-0.92), which indicates that the prediction model was able to improve the diagnostic accuracy and that it may prove a useful auxiliary diagnostic tool for malignant sub-pleural solid masses, especially in primary health care institutions in developing countries.
Copyright © 2021 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Grayscale ultrasound; Lung; Malignant mass; Sub-pleural mass; Ultrasound elastography

Year:  2021        PMID: 33573845     DOI: 10.1016/j.ultrasmedbio.2021.01.017

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  1 in total

Review 1.  Role of ultrasound in the treatment of pediatric infectious diseases: case series and narrative review.

Authors:  Takahiro Hosokawa; Yutaka Tanami; Yumiko Sato; Kuntaro Deguchi; Haruka Takei; Eiji Oguma
Journal:  World J Pediatr       Date:  2022-09-21       Impact factor: 9.186

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.